5/28
08:24 am
lgvn
Longeveron® to Attend BIO International Convention 2024 [Yahoo! Finance]
Neutral
Report
Longeveron® to Attend BIO International Convention 2024 [Yahoo! Finance]
5/28
08:05 am
lgvn
Longeveron® to Attend BIO International Convention 2024
Low
Report
Longeveron® to Attend BIO International Convention 2024
5/17
11:07 am
lgvn
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
5/14
04:16 pm
lgvn
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/14
04:05 pm
lgvn
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
5/10
04:23 pm
lgvn
Longeveron Announces Board of Directors Planned Transitions [Yahoo! Finance]
High
Report
Longeveron Announces Board of Directors Planned Transitions [Yahoo! Finance]
5/10
04:05 pm
lgvn
Longeveron Announces Board of Directors Planned Transitions
High
Report
Longeveron Announces Board of Directors Planned Transitions
5/2
08:07 am
lgvn
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 [Yahoo! Finance]
Low
Report
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 [Yahoo! Finance]
5/2
08:03 am
lgvn
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Low
Report
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
4/29
01:03 pm
lgvn
Longeveron Inc. (NASDAQ: LGVN) had its price target raised by analysts at HC Wainwright from $6.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Longeveron Inc. (NASDAQ: LGVN) had its price target raised by analysts at HC Wainwright from $6.00 to $12.00. They now have a "buy" rating on the stock.
4/25
04:08 pm
lgvn
Longeveron to Present at the Planet MicroCap Showcase [Yahoo! Finance]
Low
Report
Longeveron to Present at the Planet MicroCap Showcase [Yahoo! Finance]
4/25
04:05 pm
lgvn
Longeveron to Present at the Planet MicroCap Showcase
Medium
Report
Longeveron to Present at the Planet MicroCap Showcase
4/18
04:09 pm
lgvn
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]
Medium
Report
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]
4/18
04:05 pm
lgvn
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
Medium
Report
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
4/17
08:10 am
lgvn
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds [Yahoo! Finance]
High
Report
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds [Yahoo! Finance]
4/17
08:00 am
lgvn
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
High
Report
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4/15
10:10 am
lgvn
Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]
High
Report
Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]
4/15
08:39 am
lgvn
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC) [Yahoo! Finance]
High
Report
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC) [Yahoo! Finance]
4/15
08:30 am
lgvn
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
High
Report
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
4/11
05:20 pm
lgvn
Longeveron Announces Closing of $5.2 Million Public Offering [Yahoo! Finance]
High
Report
Longeveron Announces Closing of $5.2 Million Public Offering [Yahoo! Finance]
4/11
05:17 pm
lgvn
Longeveron Announces Closing of $5.2 Million Public Offering
High
Report
Longeveron Announces Closing of $5.2 Million Public Offering
4/8
02:31 pm
lgvn
Longeveron Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
Medium
Report
Longeveron Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
4/8
02:15 pm
lgvn
Longeveron Announces Pricing of $5.25 Million Public Offering
High
Report
Longeveron Announces Pricing of $5.25 Million Public Offering
4/8
12:00 pm
lgvn
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
4/8
10:25 am
lgvn
Longeveron stock rallies 75% amid public offering, business update [Seeking Alpha]
High
Report
Longeveron stock rallies 75% amid public offering, business update [Seeking Alpha]